Articles

Title

Date Published

Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells.

March 27, 2008

A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.

March 26, 2008

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT((R))) Randomized Controlled Trial.

March 26, 2008

Iron and anemia in human biology: a review of mechanisms.

March 25, 2008

Red cell transfusion in medicine: future challenges

March 24, 2008

Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial.

March 24, 2008

Haemoglobin, oxygen carriers and perioperative organ perfusion.

March 22, 2008

Red cell transfusion in medicine: Future challenges.

March 21, 2008

Duration of red-cell storage and complications after cardiac surgery.

March 20, 2008

Editorial: New blood, old blood, or no blood?

March 20, 2008

Effectiveness and safety of tranexamic acid administration during total knee arthroplasty.

March 18, 2008

Restrictive red blood cell transfusion: not just for the stable intensive care unit patient.

March 18, 2008

Update of nutrient-deficiency anemia in elderly patients.

March 14, 2008

The proteome of red cell membranes and vesicles during storage in blood bank conditions.

March 12, 2008

The role of intravenous iron in anemia management and transfusion avoidance.

March 12, 2008

Acute perioperative normovolaemic haemodilution in major maxillofacial surgery.

March 3, 2008

Bloodless cardiac surgery and the pediatric patient: a case study.

March 1, 2008

Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.

March 1, 2008

Novel antithrombotic agents and the risk of bleeding.

March 1, 2008

Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).

March 1, 2008